Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects

•The RELN and GAD1 mRNA levels were reduced in ASD PFC.•TET 1, 2, and 3 mRNAs were increased in ASD PFC.•There was increased DNMT1 and MECP2 promoter binding.•5mC and 5hmC levels in the promoters do not account for the increased binding. These data and a study on the cerebella from the same ASD coho...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of developmental neuroscience Vol. 62; no. 1; pp. 63 - 72
Main Authors Zhubi, Adrian, Chen, Ying, Guidotti, Alessandro, Grayson, Dennis R.
Format Journal Article
LanguageEnglish
Published United States Elsevier Ltd 01.11.2017
Elsevier BV
Subjects
DNA
RNA
TET
5fC
ASD
CB
CON
IP
5mC
FC
BA
Online AccessGet full text

Cover

Loading…
Abstract •The RELN and GAD1 mRNA levels were reduced in ASD PFC.•TET 1, 2, and 3 mRNAs were increased in ASD PFC.•There was increased DNMT1 and MECP2 promoter binding.•5mC and 5hmC levels in the promoters do not account for the increased binding. These data and a study on the cerebella from the same ASD cohort are discussed. Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down-regulation of genes expressed in GABAergic neurons in ASD brains. We measured mRNA levels corresponding to selected GABAergic genes using qRT-PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP). We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten-eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there were decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments. Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down-regulated in post-mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed.
AbstractList Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down‐regulation of genes expressed in GABAergic neurons in ASD brains. We measured mRNA levels corresponding to selected GABAergic genes using qRT‐PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5‐methylcytosine (5mC) and 5‐hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP). We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten‐eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there were decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments. Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down‐regulated in post‐mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed.
Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down-regulation of genes expressed in GABAergic neurons in ASD brains. We measured mRNA levels corresponding to selected GABAergic genes using qRT-PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP). We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten-eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there was decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments. Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down-regulated in post-mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed.
Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down-regulation of genes expressed in GABAergic neurons in ASD brains. We measured mRNA levels corresponding to selected GABAergic genes using qRT-PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP). We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten-eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there were decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments. Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down-regulated in post-mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed.Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down-regulation of genes expressed in GABAergic neurons in ASD brains. We measured mRNA levels corresponding to selected GABAergic genes using qRT-PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP). We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten-eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there were decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments. Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down-regulated in post-mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed.
Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down-regulation of genes expressed in GABAergic neurons in ASD brains. We measured mRNA levels corresponding to selected GABAergic genes using qRT-PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP). We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten-eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there were decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments. Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down-regulated in post-mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed.
•The RELN and GAD1 mRNA levels were reduced in ASD PFC.•TET 1, 2, and 3 mRNAs were increased in ASD PFC.•There was increased DNMT1 and MECP2 promoter binding.•5mC and 5hmC levels in the promoters do not account for the increased binding. These data and a study on the cerebella from the same ASD cohort are discussed. Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down-regulation of genes expressed in GABAergic neurons in ASD brains. We measured mRNA levels corresponding to selected GABAergic genes using qRT-PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP). We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten-eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there were decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments. Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down-regulated in post-mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed.
Author Guidotti, Alessandro
Zhubi, Adrian
Grayson, Dennis R.
Chen, Ying
AuthorAffiliation 4 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. dgrayson@psych.uic.edu
2 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. Ychen@psych.uic.edu
3 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. Aguidotti@psych.uic.edu
1 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. Adrian.Zhubi@osfhealthcare.org
AuthorAffiliation_xml – name: 2 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. Ychen@psych.uic.edu
– name: 1 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. Adrian.Zhubi@osfhealthcare.org
– name: 4 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. dgrayson@psych.uic.edu
– name: 3 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. Aguidotti@psych.uic.edu
Author_xml – sequence: 1
  givenname: Adrian
  surname: Zhubi
  fullname: Zhubi, Adrian
  email: Adrian.Zhubi@osfhealthcare.org
– sequence: 2
  givenname: Ying
  surname: Chen
  fullname: Chen, Ying
  email: Ychen@psych.uic.edu
– sequence: 3
  givenname: Alessandro
  surname: Guidotti
  fullname: Guidotti, Alessandro
  email: Aguidotti@psych.uic.edu
– sequence: 4
  givenname: Dennis R.
  surname: Grayson
  fullname: Grayson, Dennis R.
  email: dgrayson@psych.uic.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28229923$$D View this record in MEDLINE/PubMed
BookMark eNqNkVFv0zAUhS00xLrCX5gs8dI9tNhxEqcSQqvabrSqigQM8Wa59k3nKLWLnRT273HoNsFexpMl33OOz_V3hk6ss4DQOSUjSmj-rhqZSsPBQjtKCOUjkowIYS9QjxacDVOefj9BPcJZPsx4WpyisxAqQkiWkfQVOk2KJBmPE9ZD9XxvtmChMQp72La1bIyz2JX483y1xtJqfD2ZUWwsbm4Bl97ZRtZYOd_ALzy4ml50Wtk2Juxw2INqfLvD2gTnNXg8mHyZXeDQbqo4Ca_Ry1LWAd7cn310czX_Ov04XH26Xkwnq6HKaNc-TSWTacF5VoxpqVlZaJ4zXqhCq3wjqdaxe64TnW9ovikV4yonXMoctNacsD76cMzdt5sdaAW28bIWe2920t8JJ434d2LNrdi6g8gyno2LLmBwH-DdjxZCI3YmKKhracG1QcRPplmWsYRF6dsn0sq13sb1BB3nRUpoGmV9dP53o8cqDyCiID8KlHcheCgfJZSIjrioxANx0REXJBGReDS-f2JUpvkDMW5m6ufti6P9p6nh7j8fFcvZerlYzubf1vOb7p4kx6zLYxZEtgcDXgRlwCrQxkf8QjvzXJ3fgIHh0g
CitedBy_id crossref_primary_10_1055_s_0041_1735540
crossref_primary_10_51847_DysH69LijA
crossref_primary_10_3390_ijms25073881
crossref_primary_10_1016_j_ijdevneu_2019_04_004
crossref_primary_10_3390_biom14040437
crossref_primary_10_2217_epi_2022_0184
crossref_primary_10_1016_j_heliyon_2021_e06105
crossref_primary_10_1016_j_neuroscience_2023_08_028
crossref_primary_10_3390_ph11020056
crossref_primary_10_1016_j_ijdevneu_2017_08_002
crossref_primary_10_3389_fped_2019_00225
crossref_primary_10_1007_s11356_020_09819_5
crossref_primary_10_3389_fnmol_2025_1546083
crossref_primary_10_3390_cells11213439
crossref_primary_10_3390_microorganisms6040107
crossref_primary_10_3389_fncel_2019_00385
crossref_primary_10_12677_ACM_2021_113169
crossref_primary_10_3390_cells13131095
crossref_primary_10_1093_eep_dvae023
crossref_primary_10_2217_epi_2022_0179
crossref_primary_10_1016_j_ebiom_2022_104091
crossref_primary_10_1016_j_mam_2019_07_004
crossref_primary_10_1097_MD_0000000000034420
crossref_primary_10_1016_j_envres_2018_05_020
crossref_primary_10_3389_fncel_2018_00078
crossref_primary_10_1093_ijnp_pyx075
crossref_primary_10_1515_revneuro_2021_0014
crossref_primary_10_1007_s12311_021_01264_5
crossref_primary_10_3389_fneur_2021_612817
crossref_primary_10_3389_fnmol_2023_1275697
crossref_primary_10_1186_s40478_021_01190_x
crossref_primary_10_3389_fncel_2024_1499719
crossref_primary_10_3390_cells13242036
crossref_primary_10_1017_pcm_2024_2
crossref_primary_10_1111_pcn_12606
crossref_primary_10_1007_s12272_019_01196_z
crossref_primary_10_3390_biom10060964
crossref_primary_10_3390_jcm8122088
crossref_primary_10_1038_s41392_022_01081_0
crossref_primary_10_3390_ijms23169188
crossref_primary_10_3390_ijms24119138
crossref_primary_10_3389_fnmol_2018_00423
crossref_primary_10_1016_j_jpsychires_2021_06_013
crossref_primary_10_1007_s42764_025_00147_x
crossref_primary_10_1016_j_fct_2022_113423
crossref_primary_10_3390_ijms23073861
crossref_primary_10_2217_epi_2021_0494
Cites_doi 10.1016/S0006‐3223(02)01430‐0
10.1038/nrn3475
10.1016/B978‐0‐12‐801311‐3.00006‐8
10.1016/j.jpsychires.2011.06.001
10.1093/nar/gkf401
10.1186/1741‐7015‐7‐62
10.1093/nar/gku1305
10.1080/15592294.2015.1114202
10.1016/j.cell.2012.11.022
10.1093/nar/gkw1197
10.1038/nature14319
10.1007/s10803‐006‐0226‐7
10.1001/archpsyc.57.11.1061
10.1038/nrn3956
10.1111/j.1471‐4159.2010.06858.x
10.1038/nature10524
10.1016/j.tins.2005.03.010
10.1038/tp.2016.87
10.1007/s12311‐008‐0075‐3
10.1038/tp.2014.87
10.1007/s10803‐012‐1543‐7
10.1023/A:1013238809666
10.1007/s12035‐015‐9658‐4
10.3389/fnins.2016.00601
10.1007/s00401-006-0176-3
10.1007/s00018-016-2304-0
10.1038/nature10110
10.1038/nature20612
10.1016/j.cell.2015.06.034
10.2478/s13380-011-0016-3
10.1016/j.mehy.2014.04.014
10.1007/s10803‐014‐2078‐x
10.1038/tp.2015.191
10.1073/pnas.1031602100
10.1038/374719a0
10.1038/nrn.2016.41
10.2217/epi.15.92
10.1016/j.neuropharm.2012.04.013
10.1038/ncomms6748
10.1073/pnas.95.26.15718
10.1086/433195
10.1002/ajmg.b.31148
10.1007/s10803‐009‐0924‐z
10.1038/npp.2012.125
10.1016/j.mam.2005.12.003
10.1016/S0092‐8674(00)80782‐5
10.1038/tp.2013.123
10.1002/aur.62
10.1002/ajmg.b.30038
10.1186/gb-2014-15-3-r49
10.1038/ejhg.2012.243
10.1002/ajmg.b.32377
10.1007/s10803‐008‐0646‐7
10.1016/S1474‐4422(02)001606
10.1002/aur.188
10.1016/j.biopsych.2015.12.008
10.1177/0883073810384869
10.1016/j.neuropharm.2010.09.017
ContentType Journal Article
Copyright 2017 ISDN
Copyright © 2017 ISDN. Published by Elsevier Ltd. All rights reserved.
Copyright Elsevier BV Nov 2017
Copyright_xml – notice: 2017 ISDN
– notice: Copyright © 2017 ISDN. Published by Elsevier Ltd. All rights reserved.
– notice: Copyright Elsevier BV Nov 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QR
7TK
7U7
8FD
C1K
FR3
P64
7X8
5PM
DOI 10.1016/j.ijdevneu.2017.02.003
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Chemoreception Abstracts
Neurosciences Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
Toxicology Abstracts
Chemoreception Abstracts
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList

CrossRef
MEDLINE - Academic
MEDLINE
Technology Research Database

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1873-474X
EndPage 72
ExternalDocumentID PMC5575980
28229923
10_1016_j_ijdevneu_2017_02_003
JDNJIJDEVNEU201702003
S0736574817300035
Genre article
Journal Article
GrantInformation_xml – fundername: NIMH NIH HHS
  grantid: R01 MH093348
– fundername: NIMH NIH HHS
  grantid: R01 MH101043
– fundername: NIAAA NIH HHS
  grantid: P50 AA022538
– fundername: NIMH NIH HHS
  grantid: R24 MH068855
GroupedDBID ---
--K
--M
-~X
.GJ
.~1
0R~
1B1
1OB
1OC
1RT
1~.
1~5
29J
33P
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAHHS
AAIKJ
AAKOC
AALRI
AANLZ
AAOAW
AAQFI
AAQXK
AAXLA
AAXUO
ABCQJ
ABCUV
ABFRF
ABGSF
ABIVO
ABJNI
ABMAC
ABQWH
ABXDB
ABYKQ
ACCFJ
ACCZN
ACDAQ
ACGFO
ACGFS
ACGOF
ACIUM
ACIWK
ACPOU
ACPRK
ACXQS
ADBBV
ADBTR
ADEZE
ADKYN
ADMUD
ADUVX
ADZMN
ADZOD
AEEZP
AEFWE
AEIGN
AEKER
AENEX
AEQDE
AEUYR
AFFPM
AFRAH
AFTJW
AGHFR
AGRDE
AGUBO
AGWIK
AGYEJ
AHBTC
AHHHB
AITUG
AIURR
AIWBW
AJBDE
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMFUW
AMYDB
ASPBG
AVWKF
AZFZN
BFHJK
BLXMC
C45
CS3
DCZOG
DOVZS
DU5
EBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
G-2
G-Q
GAKWD
GBLVA
HMQ
HVGLF
HZ~
IHE
J1W
LATKE
LEEKS
M2V
M41
MEWTI
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
RJQFR
ROL
RPZ
SAMSI
SCC
SDF
SDG
SDP
SES
SEW
SNS
SSZ
SUPJJ
T5K
TEORI
UNMZH
WUQ
WXSBR
ZGI
~G-
AAHQN
AAIPD
AAMNL
AAYCA
ABWVN
ACRPL
ADNMO
AFWVQ
AITYG
ALVPJ
HGLYW
AAYWO
AAYXX
ACVFH
ADCNI
AEUPX
AEYWJ
AFPUW
AGHNM
AGQPQ
AGYGG
AIGII
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QR
7TK
7U7
8FD
C1K
FR3
P64
7X8
5PM
ID FETCH-LOGICAL-c5173-444a3a48775891fd3f8d76378c8dc6ba1dd9236d2d6b16bfc37c607aa6eddd703
IEDL.DBID .~1
ISSN 0736-5748
1873-474X
IngestDate Thu Aug 21 14:01:53 EDT 2025
Fri Jul 11 06:17:39 EDT 2025
Sat Jul 26 02:15:09 EDT 2025
Mon Jul 21 05:52:01 EDT 2025
Thu Apr 24 22:58:07 EDT 2025
Tue Jul 01 01:06:45 EDT 2025
Wed Jan 22 16:34:04 EST 2025
Fri Feb 23 02:34:04 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords GABRB3
DNMT1
OXTR
TET
Chromatin
Transcription
5caC
ChIP
ACTB
5hmC
MECP2
5fC
ASD
RELN
Repressors
RETT
BDNF-Tot
CB
MeDIP
Hydroxymethylcytosine
CON
BDNF
GAD1
IP
qRT-PCR
GAD2
5mC
Gene expression
hMeDIP
BDNF-IV
BDNF-IX
REST
Methylcytosine
GABA
GABA neuron
FC
GAPDH
BA
Language English
License Copyright © 2017 ISDN. Published by Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5173-444a3a48775891fd3f8d76378c8dc6ba1dd9236d2d6b16bfc37c607aa6eddd703
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 28229923
PQID 1968401432
PQPubID 2045467
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5575980
proquest_miscellaneous_1871555323
proquest_journals_1968401432
pubmed_primary_28229923
crossref_primary_10_1016_j_ijdevneu_2017_02_003
crossref_citationtrail_10_1016_j_ijdevneu_2017_02_003
wiley_primary_10_1016_j_ijdevneu_2017_02_003_JDNJIJDEVNEU201702003
elsevier_sciencedirect_doi_10_1016_j_ijdevneu_2017_02_003
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2017
PublicationDateYYYYMMDD 2017-11-01
PublicationDate_xml – month: 11
  year: 2017
  text: November 2017
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Oxford
PublicationTitle International journal of developmental neuroscience
PublicationTitleAlternate Int J Dev Neurosci
PublicationYear 2017
Publisher Elsevier Ltd
Elsevier BV
Publisher_xml – name: Elsevier Ltd
– name: Elsevier BV
References Yip, Soghomonian, Blatt (bib0275) 2007; 113
Colantuoni, Lipska, Ye, Hyde, Tao, Leek, Colantuoni, Elkahloun, Herman, Weinberger, Kleinman (bib0060) 2011; 478
Berg, Plioplys, Tuchman (bib0020) 2011; 26
Chen, Sharma, Costa, Costa, Grayson (bib0050) 2002; 30
Matrisciano, Tueting, Dalal, Kadriu, Grayson, Davis, Nicoletti, Guidotti (bib0205) 2013; 68
Represa, Ben-Ari (bib0240) 2005; 28
Ciernia, LaSalle (bib0055) 2016; 17
Chen, Dong, Grayson (bib0045) 2011; 60
Fatemi, Reutiman, Folsom, Rooney, Patel, Thuras (bib0100) 2010; 40
Mellén, Ayata, Dewell, Kriaucionis, Heintz (bib0215) 2012; 151
Fatemi, Reutiman, Folsom, Thuras (bib0095) 2009; 39
Ma, Whitehead, Menold, Martin, Ashley-Koch, Mei, Ritchie, Delong, Abramson, Wright, Cuccaro, Hussman, Gilbert, Pericak-Vance (bib0195) 2005; 77
Oblak, Rosene, Kemper, Bauman, Blatt (bib0225) 2011; 4
Button, Ioannidis, Mokrysz, Nosek, Flint, Robinson, Munafò (bib0030) 2013; 14
Ellis, Panitch, West, Arking (bib0080) 2016; 6
Yip, Soghomonian, Blatt (bib0280) 2009; 2
Ben-Ari (bib0015) 2015; 16
Wen, Li, Yan, Tan, Li, Zhao, Wang, Xie, Zhang, Song, Yu, Liu, Zhu, Li, Hou, Guo, Wu, He, Li, Tang, Qiao (bib0265) 2014; 15
Impagnatiello, Guidotti, Pesold, Dwivedi, Caruncho, Pisu, Uzunov, Smalheiser, Davis, Pandey, Pappas, Tueting, Sharma, Costa (bib0165) 1998; 95
Chang, Pauls, Lange, Sasanfar, Santangelo (bib0040) 2011; 156
Fatemi, Folsom, Reutiman, Thuras (bib0090) 2009; 8
McCauley, Olson, Delahanty, Amin, Nurmi, Organ, Jacobs, Folstein, Haines, Sutcliffe (bib0210) 2004; 131B
James, Shpyleva, Melnyk, Pavliv, Pogribny (bib0170) 2014; 4
Richetto, Chesters, Cattaneo, Labouesse, Gutierrez, Wood, Luoni, Meyer, Vernon, Riva (bib0245) 2016
Labouesse, Dong, Grayson, Guidotti, Meyer (bib0185) 2015; 10
Piton, Jouan, Rochefort, Dobrzeniecka, Lachapelle, Dion, Gauthier, Rouleau (bib0235) 2013; 21
Gregory, Connelly, Towers, Johnson, Biscocho, Markunas, Lintas, Abramson, Wright, Ellis, Langford, Worley, Delong, Murphy, Cuccaro, Persico, Pericak-Vance (bib0135) 2009; 7
Grayson, Guidotti (bib0130) 2016; 8
Mariani, Coppola, Zhang, Abyzov, Provini, Tomasini, Amenduni, Szekely, Palejev, Wilson, Gerstein, Grigorenko, Chawarska, Pelphrey, Howe, Vaccarino (bib0200) 2015; 162
Kang, Barnes (bib0175) 2013; 43
Abasolo, Torrell, Roig, Moyano, Vilella, Martorell (bib0005) 2011; 45
Zhubi, Chen, Dong, Cook, Guidotti, Grayson (bib0295) 2014; 4
Ludwig, Zhang, Hastert, Meyer, Rausch, Herce, Müller, Lehmkuhl, Hellmann, Trummer, Storm, Leonhardt, Cardoso (bib0190) 2016
Ansel, Rosenzweig, Zisman, Melamed, Gesundheit (bib0010) 2017; 10
Voineagu, Wang, Johnston, Lowe, Tian, Horvath, Mill, Cantor, Blencowe, Geschwind (bib0260) 2011; 474
Casanova (bib0035) 2014; 83
Fleige, Pfaffl (bib0110) 2006; 27
Grayson, Guidotti (bib0125) 2013; 38
Zhao, Zhu, Yu, Qiu, Zhang, He, Zhang (bib0285) 2017; 54
Williams, Casanova (bib0270) 2011; 2
Tuchman, Rapin (bib0255) 2002; 1
Oblak, Gibbs, Blatt (bib0220) 2010; 114
Gabel, Kinde, Stroud, Gilbert, Harmin, Kastan, Hemberg, Ebert, Greenberg (bib0115) 2015; 522
Parikshak, Swarup, Belgard, Irimia, Ramaswami, Gandal, Hartl, Leppa, Ubieta, Huang, Lowe, Blencowe, Horvath, Geschwind (bib0230) 2016; 540
Guptill, Booker, Gibbs, Kemper, Bauman, Blatt (bib0150) 2007; 37
Zhubi, Cook, Guidotti, Grayson (bib0290) 2014; 115
Fatemi, Halt, Stary, Kanodia, Schulz, Realmuto (bib0085) 2002; 52
Gokoolparsadh, Sutton, Charamko, Green, Pardy, Voineagu (bib0120) 2016; 73
Trommsdorff, Gotthardt, Hiesberger, Shelton, Stockinger, Nimpf, Hammer, Richardson, Herz (bib0250) 1999; 97
Gupta, Ellis, Ashar, Moes, Bader, Zhan, West, Arking (bib0145) 2014; 5
D’Arcangelo, Miao, Chen, Soares, Morgan, Curran (bib0065) 1995; 374
Dong, Caruncho, Liu, Smalheiser, Grayson, Costa, Guidotti (bib0070) 2003; 100
Illingworth, Gruenewald-Schneider, De Sousa, Webb, Merusi, Kerr, James, Smith, Walker, Andrews, Bird (bib0160) 2015; 43
King, Walum, Inoue, Eyrich, Young (bib0180) 2015
Dong, Tueting, Matrisciano, Grayson, Guidotti (bib0075) 2016; 6
Guidotti, Auta, Davis, Di-Giorgi-Gerevini, Dwivedi, Grayson, Impagnatiello, Pandey, Pesold, Sharma, Uzunov, Costa (bib0140) 2000; 57
Blatt, Fitzgerald, Guptill, Booker, Kemper, Bauman (bib0025) 2001; 31
Fatemi, Reutiman, Folsom, Rustan, Rooney, Thuras (bib0105) 2014; 44
Harrison, Gamsiz, Berkowitz, Nagpal, Jerskey (bib0155) 2015; 168
2011; 478
2002; 52
2013; 21
2013; 68
2011; 60
2016; 540
2016; 73
1995; 374
2005; 28
2011; 156
2011; 474
2007; 37
2014; 5
2013; 14
2014; 4
2000; 57
2006; 27
2010; 114
2015; 43
2014; 15
1999; 97
2011; 26
1998; 95
2005; 77
2015; 162
2015; 16
2011; 2
2002; 30
2015; 522
2013; 43
2015; 168
2015; 10
2002; 1
2011; 4
2016; 17
2014; 83
2010; 40
2014; 44
2014; 115
2012; 151
2016; 6
2007; 113
2013; 38
2004; 131B
2017; 10
2017; 54
2009; 8
2009; 7
2016
2011; 45
2015
2009; 2
2003; 100
2016; 8
2001; 31
2009; 39
e_1_2_10_46_1
e_1_2_10_21_1
e_1_2_10_44_1
e_1_2_10_42_1
e_1_2_10_40_1
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_53_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_39_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_37_1
e_1_2_10_57_1
e_1_2_10_58_1
e_1_2_10_13_1
e_1_2_10_34_1
e_1_2_10_11_1
e_1_2_10_32_1
e_1_2_10_30_1
e_1_2_10_51_1
e_1_2_10_29_1
e_1_2_10_27_1
Williams E.L. (e_1_2_10_55_1) 2011; 2
e_1_2_10_48_1
e_1_2_10_24_1
e_1_2_10_45_1
e_1_2_10_22_1
e_1_2_10_43_1
e_1_2_10_20_1
e_1_2_10_41_1
Yip J. (e_1_2_10_56_1) 2007; 113
Fleige S. (e_1_2_10_23_1) 2006; 27
e_1_2_10_52_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_54_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_38_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_36_1
e_1_2_10_12_1
e_1_2_10_35_1
e_1_2_10_9_1
e_1_2_10_59_1
e_1_2_10_10_1
e_1_2_10_33_1
e_1_2_10_31_1
Richetto J. (e_1_2_10_50_1) 2016
Gokoolparsadh A. (e_1_2_10_25_1) 2016; 73
e_1_2_10_60_1
e_1_2_10_28_1
e_1_2_10_49_1
e_1_2_10_26_1
e_1_2_10_47_1
References_xml – volume: 113
  start-page: 559
  year: 2007
  end-page: 568
  ident: bib0275
  article-title: Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications
  publication-title: Acta Neuropathol. (Berl.)
– volume: 374
  start-page: 719
  year: 1995
  end-page: 723
  ident: bib0065
  article-title: A protein related to extracellular matrix proteins deleted in the mouse mutant reeler
  publication-title: Nature
– volume: 16
  start-page: 498
  year: 2015
  end-page: 505
  ident: bib0015
  article-title: Is birth a critical period in the pathogenesis of autism spectrum disorders?
  publication-title: Nat. Rev. Neurosci.
– volume: 8
  start-page: 64
  year: 2009
  end-page: 69
  ident: bib0090
  article-title: Expression of GABA(B) receptors is altered in brains of subjects with autism
  publication-title: Cerebellum
– volume: 37
  start-page: 911
  year: 2007
  end-page: 920
  ident: bib0150
  article-title: [3H]-flunitrazepam-labeled benzodiazepine binding sites in the hippocampal formation in autism: a multiple concentration autoradiographic study
  publication-title: J. Autism Dev. Disord.
– volume: 114
  start-page: 1414
  year: 2010
  end-page: 1423
  ident: bib0220
  article-title: Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism
  publication-title: J. Neurochem.
– volume: 6
  start-page: e711
  year: 2016
  ident: bib0075
  article-title: Behavioral and molecular neuroepigenetic alterations in prenatally stressed mice: relevance for the study of chromatin remodeling properties of antipsychotic drugs
  publication-title: Transl. Psychiatry
– volume: 131B
  start-page: 51
  year: 2004
  end-page: 59
  ident: bib0210
  article-title: A linkage disequilibrium map of the 1-Mb 15q12 GABA(A) receptor subunit cluster and association to autism
  publication-title: Am. J. Med. Genet. B: Neuropsychiatr. Genet.
– volume: 6
  start-page: e817
  year: 2016
  ident: bib0080
  article-title: Transcriptome analysis of cortical tissue reveals shared sets of downregulated genes in autism and schizophrenia
  publication-title: Transl. Psychiatry
– volume: 115
  start-page: 203
  year: 2014
  end-page: 244
  ident: bib0290
  article-title: Epigenetic mechanisms in autism spectrum disorder
  publication-title: Int. Rev. Neurobiol.
– volume: 83
  start-page: 32
  year: 2014
  end-page: 38
  ident: bib0035
  article-title: Autism as a sequence: from heterochronic germinal cell divisions to abnormalities of cell migration and cortical dysplasias
  publication-title: Med. Hypotheses
– volume: 7
  start-page: 62
  year: 2009
  ident: bib0135
  article-title: Genomic and epigenetic evidence for oxytocin receptor deficiency in autism
  publication-title: BMC Med.
– volume: 39
  start-page: 223
  year: 2009
  end-page: 230
  ident: bib0095
  article-title: GABA(A) receptor downregulation in brains of subjects with autism
  publication-title: J. Autism Dev. Disord.
– volume: 10
  start-page: 1143
  year: 2015
  end-page: 1155
  ident: bib0185
  article-title: Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex
  publication-title: Epigenetics
– volume: 4
  start-page: 200
  year: 2011
  end-page: 211
  ident: bib0225
  article-title: Altered posterior cingulate cortical cyctoarchitecture, but normal density of neurons and interneurons in the posterior cingulate cortex and fusiform gyrus in autism
  publication-title: Autism Res.
– year: 2015
  ident: bib0180
  article-title: Variation in the oxytocin receptor gene predicts brain region-specific expression and social attachment
  publication-title: Biol. Psychiatry
– volume: 30
  start-page: 2930
  year: 2002
  end-page: 2939
  ident: bib0050
  article-title: On the epigenetic regulation of the human reelin promoter
  publication-title: Nucleic Acids Res.
– volume: 57
  start-page: 1061
  year: 2000
  end-page: 1069
  ident: bib0140
  article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study
  publication-title: Arch. Gen. Psychiatry
– volume: 10
  start-page: 601
  year: 2017
  ident: bib0010
  article-title: Variation in gene expression in autism spectrum disorders: an extensive review of transcriptomic studies
  publication-title: Front. Neurosci.
– volume: 95
  start-page: 15718
  year: 1998
  end-page: 15723
  ident: bib0165
  article-title: A decrease of reelin expression as a putative vulnerability factor in schizophrenia
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 54
  start-page: 541
  year: 2017
  end-page: 550
  ident: bib0285
  article-title: Brain REST/NRSF is not only a silent repressor but also an active protector
  publication-title: Mol. Neurobiol.
– volume: 44
  start-page: 1833
  year: 2014
  end-page: 1845
  ident: bib0105
  article-title: Downregulation of GABAA receptor protein subunits α6, β2, δ, ε, γ2, θ, and ρ2 in superior frontal cortex of subjects with autism
  publication-title: J. Autism Dev. Disord.
– volume: 43
  start-page: 68
  year: 2013
  end-page: 79
  ident: bib0175
  article-title: A common susceptibility factor of both autism and epilepsy: functional deficiency of GABA A receptors
  publication-title: J. Autism Dev. Disord.
– volume: 474
  start-page: 380
  year: 2011
  end-page: 384
  ident: bib0260
  article-title: Transcriptomic analysis of autistic brain reveals convergent molecular pathology
  publication-title: Nature
– volume: 45
  start-page: 1411
  year: 2011
  end-page: 1418
  ident: bib0005
  article-title: RT-qPCR study on post-mortem brain samples from patients with major psychiatric disorders: reference genes and specimen characteristics
  publication-title: J. Psychiatr. Res.
– volume: 68
  start-page: 184
  year: 2013
  end-page: 194
  ident: bib0205
  article-title: Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice
  publication-title: Neuropharmacology
– volume: 28
  start-page: 278
  year: 2005
  end-page: 283
  ident: bib0240
  article-title: Trophic actions of GABA on neuronal development
  publication-title: Trends Neurosci.
– year: 2016
  ident: bib0190
  article-title: Binding of MBD proteins to DNA blocks Tet1 function thereby modulating transcriptional noise
  publication-title: Nucleic Acids Res.
– volume: 60
  start-page: 1075
  year: 2011
  end-page: 1087
  ident: bib0045
  article-title: Analysis of the GAD1 promoter: trans-acting factors and DNA methylation converge on the 5′ untranslated region
  publication-title: Neuropharmacology
– volume: 21
  start-page: 749
  year: 2013
  end-page: 756
  ident: bib0235
  article-title: Analysis of the effects of rare variants on splicing identifies alterations in GABAA receptor genes in autism spectrum disorder individuals
  publication-title: Eur. J. Hum. Genet.
– volume: 31
  start-page: 537
  year: 2001
  end-page: 543
  ident: bib0025
  article-title: Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study
  publication-title: J. Autism Dev. Disord.
– volume: 156
  start-page: 233
  year: 2011
  end-page: 239
  ident: bib0040
  article-title: Common genetic variation in the GAD1 gene and the entire family of DLX homeobox genes and autism spectrum disorders
  publication-title: Am. J. Med. Genet. B: Neuropsychiatr. Genet.
– volume: 38
  start-page: 138
  year: 2013
  end-page: 166
  ident: bib0125
  article-title: The dynamics of DNA methylation in schizophrenia and related psychiatric disorders
  publication-title: Neuropsychopharmacology
– volume: 14
  start-page: 365
  year: 2013
  end-page: 376
  ident: bib0030
  article-title: Power failure: why small sample size undermines the reliability of neuroscience
  publication-title: Nat. Rev. Neurosci.
– volume: 478
  start-page: 519
  year: 2011
  end-page: 523
  ident: bib0060
  article-title: Temporal dynamics and genetic control of transcription in the human prefrontal cortex
  publication-title: Nature
– volume: 4
  start-page: e349
  year: 2014
  ident: bib0295
  article-title: Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum
  publication-title: Transl. Psychiatry
– volume: 100
  start-page: 5479
  year: 2003
  end-page: 5484
  ident: bib0070
  article-title: A reelin-integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 77
  start-page: 377
  year: 2005
  end-page: 388
  ident: bib0195
  article-title: Identification of significant association and gene–gene interaction of GABA receptor subunit genes in autism
  publication-title: Am. J. Hum. Genet.
– volume: 540
  start-page: 423
  year: 2016
  end-page: 427
  ident: bib0230
  article-title: Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism
  publication-title: Nature
– volume: 26
  start-page: 540
  year: 2011
  end-page: 547
  ident: bib0020
  article-title: Risk and correlates of autism spectrum disorder in children with epilepsy: a community-based study
  publication-title: J. Child Neurol.
– volume: 97
  start-page: 689
  year: 1999
  end-page: 701
  ident: bib0250
  article-title: Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2
  publication-title: Cell
– volume: 15
  start-page: R49
  year: 2014
  ident: bib0265
  article-title: Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain
  publication-title: Genome Biol.
– volume: 40
  start-page: 743
  year: 2010
  end-page: 750
  ident: bib0100
  article-title: mRNA and protein levels for GABAA alpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism
  publication-title: J. Autism Dev. Disord.
– volume: 17
  start-page: 411
  year: 2016
  end-page: 423
  ident: bib0055
  article-title: The landscape of DNA methylation amid a perfect storm of autism aetiologies
  publication-title: Nat. Rev. Neurosci.
– volume: 522
  start-page: 89
  year: 2015
  end-page: 93
  ident: bib0115
  article-title: Disruption of DNA-methylation-dependent long gene repression in Rett syndrome
  publication-title: Nature
– volume: 5
  start-page: 5748
  year: 2014
  ident: bib0145
  article-title: Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism
  publication-title: Nat. Commun.
– volume: 151
  start-page: 1417
  year: 2012
  end-page: 1430
  ident: bib0215
  article-title: MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system
  publication-title: Cell
– year: 2016
  ident: bib0245
  article-title: Genome-wide transcriptional profiling and structural magnetic resonance imaging in the maternal immune activation model of neurodevelopmental disorders
  publication-title: Cereb. Cortex
– volume: 73
  start-page: 4517
  year: 2016
  end-page: 4520
  ident: bib0120
  article-title: Searching for convergent pathways in autism spectrum disorders: insights from human brain transcriptome studies
  publication-title: Cell. Mol. Life Sci.
– volume: 43
  start-page: 732
  year: 2015
  end-page: 744
  ident: bib0160
  article-title: Inter-individual variability contrasts with regional homogeneity in the human brain DNA methylome
  publication-title: Nucleic Acids Res.
– volume: 27
  start-page: 126
  year: 2006
  end-page: 139
  ident: bib0110
  article-title: RNA integrity and the effect on the real-time qRT-PCR performance
  publication-title: Mol. Aspects Med.
– volume: 8
  start-page: 85
  year: 2016
  end-page: 104
  ident: bib0130
  article-title: Merging data from genetic and epigenetic approaches to better understand autistic spectrum disorder
  publication-title: Epigenomics
– volume: 2
  start-page: 50
  year: 2009
  end-page: 59
  ident: bib0280
  article-title: Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study
  publication-title: Autism Res.
– volume: 52
  start-page: 805
  year: 2002
  end-page: 810
  ident: bib0085
  article-title: Glutamic acid decarboxylase 65 and 67
  publication-title: Biol. Psychiatry
– volume: 168
  start-page: 720
  year: 2015
  end-page: 729
  ident: bib0155
  article-title: Genetic variation in the oxytocin receptor gene is associated with a social phenotype in autism spectrum disorders
  publication-title: Am. J. Med. Genet. B: Neuropsychiatr. Genet.
– volume: 4
  start-page: e460
  year: 2014
  ident: bib0170
  article-title: Elevated 5-hydroxymethylcytosine in the Engrailed-2 (EN-2) promoter is associated with increased gene expression and decreased MeCP2 binding in autism cerebellum
  publication-title: Transl. Psychiatry
– volume: 1
  start-page: 352
  year: 2002
  end-page: 358
  ident: bib0255
  article-title: Epilepsy in autism
  publication-title: Lancet Neurol.
– volume: 162
  start-page: 375
  year: 2015
  end-page: 390
  ident: bib0200
  article-title: FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders
  publication-title: Cell
– volume: 2
  start-page: 106
  year: 2011
  end-page: 120
  ident: bib0270
  article-title: Above genetics: lessons from cerebral development in autism
  publication-title: Transl. Neurosci.
– volume: 6
  year: 2016
  article-title: Transcriptome analysis of cortical tissue reveals shared sets of downregulated genes in autism and schizophrenia
  publication-title: Transl. Psychiatry
– volume: 522
  start-page: 89
  issue: (7554)
  year: 2015
  end-page: 93
  article-title: Disruption of DNA‐methylation‐dependent long gene repression in Rett syndrome
  publication-title: Nature
– volume: 77
  start-page: 377
  issue: (3)
  year: 2005
  end-page: 388
  article-title: Identification of significant association and gene–gene interaction of GABA receptor subunit genes in autism
  publication-title: Am. J. Hum. Genet.
– volume: 26
  start-page: 540
  year: 2011
  end-page: 547
  article-title: Risk and correlates of autism spectrum disorder in children with epilepsy: a community‐based study
  publication-title: J. Child Neurol.
– volume: 15
  start-page: R49
  year: 2014
  article-title: Whole‐genome analysis of 5‐hydroxymethylcytosine and 5‐methylcytosine at base resolution in the human brain
  publication-title: Genome Biol.
– volume: 73
  start-page: 4517
  issue: (23)
  year: 2016
  end-page: 4520
  article-title: Searching for convergent pathways in autism spectrum disorders: insights from human brain transcriptome studies
  publication-title: Cell. Mol. Life Sci.
– volume: 44
  start-page: 1833
  issue: (8)
  year: 2014
  end-page: 1845
  article-title: Downregulation of GABAA receptor protein subunits α6, β2, δ, ε, γ2, θ, and ρ2 in superior frontal cortex of subjects with autism
  publication-title: J. Autism Dev. Disord.
– volume: 21
  start-page: 749
  issue: (7)
  year: 2013
  end-page: 756
  article-title: Analysis of the effects of rare variants on splicing identifies alterations in GABAA receptor genes in autism spectrum disorder individuals
  publication-title: Eur. J. Hum. Genet.
– volume: 97
  start-page: 689
  issue: (6)
  year: 1999
  end-page: 701
  article-title: Reeler/disabled‐like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2
  publication-title: Cell
– volume: 10
  start-page: 601
  year: 2017
  article-title: Variation in gene expression in autism spectrum disorders: an extensive review of transcriptomic studies
  publication-title: Front. Neurosci.
– volume: 113
  start-page: 559
  issue: (5)
  year: 2007
  end-page: 568
  article-title: Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications
  publication-title: Acta Neuropathol. (Berl.)
– volume: 2
  start-page: 106
  issue: (2)
  year: 2011
  end-page: 120
  article-title: Above genetics: lessons from cerebral development in autism
  publication-title: Transl. Neurosci.
– volume: 4
  year: 2014
  article-title: Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5‐hmC in autism spectrum disorder (ASD) cerebellum
  publication-title: Transl. Psychiatry
– volume: 374
  start-page: 719
  year: 1995
  end-page: 723
  article-title: A protein related to extracellular matrix proteins deleted in the mouse mutant reeler
  publication-title: Nature
– volume: 95
  start-page: 15718
  issue: (26)
  year: 1998
  end-page: 15723
  article-title: A decrease of reelin expression as a putative vulnerability factor in schizophrenia
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 478
  start-page: 519
  year: 2011
  end-page: 523
  article-title: Temporal dynamics and genetic control of transcription in the human prefrontal cortex
  publication-title: Nature
– volume: 45
  start-page: 1411
  issue: (11)
  year: 2011
  end-page: 1418
  article-title: RT‐qPCR study on post‐mortem brain samples from patients with major psychiatric disorders: reference genes and specimen characteristics
  publication-title: J. Psychiatr. Res.
– volume: 27
  start-page: 126
  issue: (2–3)
  year: 2006
  end-page: 139
  article-title: RNA integrity and the effect on the real‐time qRT‐PCR performance
  publication-title: Mol. Aspects Med.
– volume: 30
  start-page: 2930
  year: 2002
  end-page: 2939
  article-title: On the epigenetic regulation of the human reelin promoter
  publication-title: Nucleic Acids Res.
– volume: 8
  start-page: 64
  issue: (1)
  year: 2009
  end-page: 69
  article-title: Expression of GABA(B) receptors is altered in brains of subjects with autism
  publication-title: Cerebellum
– volume: 16
  start-page: 498
  issue: (8)
  year: 2015
  end-page: 505
  article-title: Is birth a critical period in the pathogenesis of autism spectrum disorders?
  publication-title: Nat. Rev. Neurosci.
– volume: 57
  start-page: 1061
  issue: (11)
  year: 2000
  end-page: 1069
  article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study
  publication-title: Arch. Gen. Psychiatry
– volume: 31
  start-page: 537
  year: 2001
  end-page: 543
  article-title: Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study
  publication-title: J. Autism Dev. Disord.
– volume: 83
  start-page: 32
  issue: (1)
  year: 2014
  end-page: 38
  article-title: Autism as a sequence: from heterochronic germinal cell divisions to abnormalities of cell migration and cortical dysplasias
  publication-title: Med. Hypotheses
– volume: 131B
  start-page: 51
  issue: (1)
  year: 2004
  end-page: 59
  article-title: A linkage disequilibrium map of the 1‐Mb 15q12 GABA(A) receptor subunit cluster and association to autism
  publication-title: Am. J. Med. Genet. B: Neuropsychiatr. Genet.
– volume: 156
  start-page: 233
  issue: (2)
  year: 2011
  end-page: 239
  article-title: Common genetic variation in the GAD1 gene and the entire family of DLX homeobox genes and autism spectrum disorders
  publication-title: Am. J. Med. Genet. B: Neuropsychiatr. Genet.
– volume: 43
  start-page: 732
  issue: (2)
  year: 2015
  end-page: 744
  article-title: Inter‐individual variability contrasts with regional homogeneity in the human brain DNA methylome
  publication-title: Nucleic Acids Res.
– volume: 52
  start-page: 805
  issue: (8)
  year: 2002
  end-page: 810
  article-title: Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices
  publication-title: Biol. Psychiatry
– volume: 28
  start-page: 278
  year: 2005
  end-page: 283
  article-title: Trophic actions of GABA on neuronal development
  publication-title: Trends Neurosci.
– volume: 114
  start-page: 1414
  issue: (5)
  year: 2010
  end-page: 1423
  article-title: Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism
  publication-title: J. Neurochem.
– volume: 4
  year: 2014
  article-title: Elevated 5‐hydroxymethylcytosine in the Engrailed‐2 (EN‐2) promoter is associated with increased gene expression and decreased MeCP2 binding in autism cerebellum
  publication-title: Transl. Psychiatry
– year: 2016
  article-title: Binding of MBD proteins to DNA blocks Tet1 function thereby modulating transcriptional noise
  publication-title: Nucleic Acids Res.
– volume: 5
  start-page: 5748
  year: 2014
  article-title: Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity‐dependent genes in autism
  publication-title: Nat. Commun.
– volume: 10
  start-page: 1143
  issue: (12)
  year: 2015
  end-page: 1155
  article-title: Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex
  publication-title: Epigenetics
– volume: 1
  start-page: 352
  issue: (6)
  year: 2002
  end-page: 358
  article-title: Epilepsy in autism
  publication-title: Lancet Neurol.
– volume: 39
  start-page: 223
  issue: (2)
  year: 2009
  end-page: 230
  article-title: GABA(A) receptor downregulation in brains of subjects with autism
  publication-title: J. Autism Dev. Disord.
– volume: 43
  start-page: 68
  issue: (1)
  year: 2013
  end-page: 79
  article-title: A common susceptibility factor of both autism and epilepsy: functional deficiency of GABA A receptors
  publication-title: J. Autism Dev. Disord.
– volume: 6
  year: 2016
  article-title: Behavioral and molecular neuroepigenetic alterations in prenatally stressed mice: relevance for the study of chromatin remodeling properties of antipsychotic drugs
  publication-title: Transl. Psychiatry
– volume: 14
  start-page: 365
  issue: (5)
  year: 2013
  end-page: 376
  article-title: Power failure: why small sample size undermines the reliability of neuroscience
  publication-title: Nat. Rev. Neurosci.
– year: 2015
  article-title: Variation in the oxytocin receptor gene predicts brain region‐specific expression and social attachment
  publication-title: Biol. Psychiatry
– volume: 68
  start-page: 184
  year: 2013
  end-page: 194
  article-title: Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia‐like phenotype induced by prenatal stress in mice
  publication-title: Neuropharmacology
– volume: 151
  start-page: 1417
  issue: (7)
  year: 2012
  end-page: 1430
  article-title: MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system
  publication-title: Cell
– volume: 60
  start-page: 1075
  issue: (7–8)
  year: 2011
  end-page: 1087
  article-title: Analysis of the GAD1 promoter: trans‐acting factors and DNA methylation converge on the 5′ untranslated region
  publication-title: Neuropharmacology
– volume: 17
  start-page: 411
  issue: (7)
  year: 2016
  end-page: 423
  article-title: The landscape of DNA methylation amid a perfect storm of autism aetiologies
  publication-title: Nat. Rev. Neurosci.
– volume: 540
  start-page: 423
  issue: (7633)
  year: 2016
  end-page: 427
  article-title: Genome‐wide changes in lncRNA, splicing, and regional gene expression patterns in autism
  publication-title: Nature
– volume: 8
  start-page: 85
  issue: (1)
  year: 2016
  end-page: 104
  article-title: Merging data from genetic and epigenetic approaches to better understand autistic spectrum disorder
  publication-title: Epigenomics
– volume: 115
  start-page: 203
  year: 2014
  end-page: 244
  article-title: Epigenetic mechanisms in autism spectrum disorder
  publication-title: Int. Rev. Neurobiol.
– volume: 7
  start-page: 62
  year: 2009
  article-title: Genomic and epigenetic evidence for oxytocin receptor deficiency in autism
  publication-title: BMC Med.
– volume: 37
  start-page: 911
  issue: (5)
  year: 2007
  end-page: 920
  article-title: [3H]‐flunitrazepam‐labeled benzodiazepine binding sites in the hippocampal formation in autism: a multiple concentration autoradiographic study
  publication-title: J. Autism Dev. Disord.
– volume: 474
  start-page: 380
  issue: (7351)
  year: 2011
  end-page: 384
  article-title: Transcriptomic analysis of autistic brain reveals convergent molecular pathology
  publication-title: Nature
– volume: 100
  start-page: 5479
  year: 2003
  end-page: 5484
  article-title: A reelin‐integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 38
  start-page: 138
  issue: (1)
  year: 2013
  end-page: 166
  article-title: The dynamics of DNA methylation in schizophrenia and related psychiatric disorders
  publication-title: Neuropsychopharmacology
– volume: 2
  start-page: 50
  issue: (1)
  year: 2009
  end-page: 59
  article-title: Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study
  publication-title: Autism Res.
– volume: 168
  start-page: 720
  issue: (8)
  year: 2015
  end-page: 729
  article-title: Genetic variation in the oxytocin receptor gene is associated with a social phenotype in autism spectrum disorders
  publication-title: Am. J. Med. Genet. B: Neuropsychiatr. Genet.
– volume: 162
  start-page: 375
  issue: (2)
  year: 2015
  end-page: 390
  article-title: FOXG1‐dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders
  publication-title: Cell
– year: 2016
  article-title: Genome‐wide transcriptional profiling and structural magnetic resonance imaging in the maternal immune activation model of neurodevelopmental disorders
  publication-title: Cereb. Cortex
– volume: 4
  start-page: 200
  issue: (3)
  year: 2011
  end-page: 211
  article-title: Altered posterior cingulate cortical cyctoarchitecture, but normal density of neurons and interneurons in the posterior cingulate cortex and fusiform gyrus in autism
  publication-title: Autism Res.
– volume: 54
  start-page: 541
  issue: (1)
  year: 2017
  end-page: 550
  article-title: Brain REST/NRSF is not only a silent repressor but also an active protector
  publication-title: Mol. Neurobiol.
– volume: 40
  start-page: 743
  issue: (6)
  year: 2010
  end-page: 750
  article-title: mRNA and protein levels for GABAA alpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism
  publication-title: J. Autism Dev. Disord.
– ident: e_1_2_10_18_1
  doi: 10.1016/S0006‐3223(02)01430‐0
– ident: e_1_2_10_7_1
  doi: 10.1038/nrn3475
– ident: e_1_2_10_59_1
  doi: 10.1016/B978‐0‐12‐801311‐3.00006‐8
– ident: e_1_2_10_2_1
  doi: 10.1016/j.jpsychires.2011.06.001
– ident: e_1_2_10_11_1
  doi: 10.1093/nar/gkf401
– ident: e_1_2_10_28_1
  doi: 10.1186/1741‐7015‐7‐62
– ident: e_1_2_10_33_1
  doi: 10.1093/nar/gku1305
– ident: e_1_2_10_38_1
  doi: 10.1080/15592294.2015.1114202
– ident: e_1_2_10_44_1
  doi: 10.1016/j.cell.2012.11.022
– ident: e_1_2_10_39_1
  doi: 10.1093/nar/gkw1197
– ident: e_1_2_10_24_1
  doi: 10.1038/nature14319
– ident: e_1_2_10_31_1
  doi: 10.1007/s10803‐006‐0226‐7
– ident: e_1_2_10_29_1
  doi: 10.1001/archpsyc.57.11.1061
– ident: e_1_2_10_4_1
  doi: 10.1038/nrn3956
– ident: e_1_2_10_45_1
  doi: 10.1111/j.1471‐4159.2010.06858.x
– ident: e_1_2_10_13_1
  doi: 10.1038/nature10524
– ident: e_1_2_10_49_1
  doi: 10.1016/j.tins.2005.03.010
– ident: e_1_2_10_17_1
  doi: 10.1038/tp.2016.87
– ident: e_1_2_10_19_1
  doi: 10.1007/s12311‐008‐0075‐3
– ident: e_1_2_10_35_1
  doi: 10.1038/tp.2014.87
– ident: e_1_2_10_36_1
  doi: 10.1007/s10803‐012‐1543‐7
– ident: e_1_2_10_6_1
  doi: 10.1023/A:1013238809666
– ident: e_1_2_10_58_1
  doi: 10.1007/s12035‐015‐9658‐4
– ident: e_1_2_10_3_1
  doi: 10.3389/fnins.2016.00601
– volume: 113
  start-page: 559
  issue: 5
  year: 2007
  ident: e_1_2_10_56_1
  article-title: Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications
  publication-title: Acta Neuropathol. (Berl.)
  doi: 10.1007/s00401-006-0176-3
– volume: 73
  start-page: 4517
  issue: 23
  year: 2016
  ident: e_1_2_10_25_1
  article-title: Searching for convergent pathways in autism spectrum disorders: insights from human brain transcriptome studies
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s00018-016-2304-0
– ident: e_1_2_10_53_1
  doi: 10.1038/nature10110
– ident: e_1_2_10_47_1
  doi: 10.1038/nature20612
– ident: e_1_2_10_41_1
  doi: 10.1016/j.cell.2015.06.034
– volume: 2
  start-page: 106
  issue: 2
  year: 2011
  ident: e_1_2_10_55_1
  article-title: Above genetics: lessons from cerebral development in autism
  publication-title: Transl. Neurosci.
  doi: 10.2478/s13380-011-0016-3
– ident: e_1_2_10_8_1
  doi: 10.1016/j.mehy.2014.04.014
– ident: e_1_2_10_22_1
  doi: 10.1007/s10803‐014‐2078‐x
– ident: e_1_2_10_16_1
  doi: 10.1038/tp.2015.191
– ident: e_1_2_10_15_1
  doi: 10.1073/pnas.1031602100
– ident: e_1_2_10_14_1
  doi: 10.1038/374719a0
– year: 2016
  ident: e_1_2_10_50_1
  article-title: Genome‐wide transcriptional profiling and structural magnetic resonance imaging in the maternal immune activation model of neurodevelopmental disorders
  publication-title: Cereb. Cortex
– ident: e_1_2_10_12_1
  doi: 10.1038/nrn.2016.41
– ident: e_1_2_10_27_1
  doi: 10.2217/epi.15.92
– ident: e_1_2_10_42_1
  doi: 10.1016/j.neuropharm.2012.04.013
– ident: e_1_2_10_30_1
  doi: 10.1038/ncomms6748
– ident: e_1_2_10_34_1
  doi: 10.1073/pnas.95.26.15718
– ident: e_1_2_10_40_1
  doi: 10.1086/433195
– ident: e_1_2_10_9_1
  doi: 10.1002/ajmg.b.31148
– ident: e_1_2_10_21_1
  doi: 10.1007/s10803‐009‐0924‐z
– ident: e_1_2_10_26_1
  doi: 10.1038/npp.2012.125
– volume: 27
  start-page: 126
  issue: 2
  year: 2006
  ident: e_1_2_10_23_1
  article-title: RNA integrity and the effect on the real‐time qRT‐PCR performance
  publication-title: Mol. Aspects Med.
  doi: 10.1016/j.mam.2005.12.003
– ident: e_1_2_10_51_1
  doi: 10.1016/S0092‐8674(00)80782‐5
– ident: e_1_2_10_60_1
  doi: 10.1038/tp.2013.123
– ident: e_1_2_10_57_1
  doi: 10.1002/aur.62
– ident: e_1_2_10_43_1
  doi: 10.1002/ajmg.b.30038
– ident: e_1_2_10_54_1
  doi: 10.1186/gb-2014-15-3-r49
– ident: e_1_2_10_48_1
  doi: 10.1038/ejhg.2012.243
– ident: e_1_2_10_32_1
  doi: 10.1002/ajmg.b.32377
– ident: e_1_2_10_20_1
  doi: 10.1007/s10803‐008‐0646‐7
– ident: e_1_2_10_52_1
  doi: 10.1016/S1474‐4422(02)001606
– ident: e_1_2_10_46_1
  doi: 10.1002/aur.188
– ident: e_1_2_10_37_1
  doi: 10.1016/j.biopsych.2015.12.008
– ident: e_1_2_10_5_1
  doi: 10.1177/0883073810384869
– ident: e_1_2_10_10_1
  doi: 10.1016/j.neuropharm.2010.09.017
SSID ssj0005504
Score 2.3964686
Snippet •The RELN and GAD1 mRNA levels were reduced in ASD PFC.•TET 1, 2, and 3 mRNAs were increased in ASD PFC.•There was increased DNMT1 and MECP2 promoter...
Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously...
Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 63
SubjectTerms 5-Methylcytosine - analogs & derivatives
5-Methylcytosine - pharmacology
Adolescent
Adult
Analysis of Variance
Autism
Autism Spectrum Disorder - genetics
Autism Spectrum Disorder - pathology
Brain
Cell Adhesion Molecules, Neuronal - genetics
Cell Adhesion Molecules, Neuronal - metabolism
Chromatin
Chromatin Immunoprecipitation
Cohort Studies
Cortex (frontal)
Deoxyribonucleic acid
DNA
DNA (Cytosine-5-)-Methyltransferase 1 - metabolism
DNMT1 protein
Epigenesis, Genetic - physiology
Epigenetics
Extracellular Matrix Proteins - genetics
Extracellular Matrix Proteins - metabolism
Female
Frontal Lobe - metabolism
GABA neuron
Gene expression
Gene regulation
Genes
Glutamate decarboxylase
Glutamate Decarboxylase - genetics
Glutamate Decarboxylase - metabolism
Humans
Hydroxymethylcytosine
Immunoprecipitation
Male
MeCP2 protein
Methyl-CpG binding protein
Methyl-CpG-Binding Protein 2 - metabolism
Methylcytosine
mRNA
Nerve Tissue Proteins - genetics
Nerve Tissue Proteins - metabolism
Neurons
Promoter Regions, Genetic
Promoters
Protein Binding - genetics
Proteins
Reelin Protein
Repressors
Ribonucleic acid
RNA
RNA, Messenger - metabolism
Serine Endopeptidases - genetics
Serine Endopeptidases - metabolism
Transcription
Translocation
Young Adult
γ-Aminobutyric acid
Title Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects
URI https://dx.doi.org/10.1016/j.ijdevneu.2017.02.003
https://onlinelibrary.wiley.com/doi/abs/10.1016%2Fj.ijdevneu.2017.02.003
https://www.ncbi.nlm.nih.gov/pubmed/28229923
https://www.proquest.com/docview/1968401432
https://www.proquest.com/docview/1871555323
https://pubmed.ncbi.nlm.nih.gov/PMC5575980
Volume 62
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF5VPXFBQHkEWrRICLUHN37swz6GxKFEkAMlqLfVviwcNU7UkAou_HZm_IgSVahIHO3dtayZ2ZlZ-5tvCHkrMsi6Ic4HQqcmYM7HgTEyCgod-RCcIYQsLHD-PBUXMza54lcHZNjVwiCssvX9jU-vvXV7p99Ks78qy_4lGKfgkqURUq6HCRaaMybRys9_78A8eN1CECcHOHunSnh-Xs6dv638BiFesuHuTP4WoO4moHdxlLv5bR2gxo_IwzazpIPm5R-TA189IUeDCk7Vi1_0Ha2xnvVH9CNyna-QhRMLGOlN040e9EOXBf2Sf5pSXTn6YTCKaFlRSBBpgSwH8GyLyNyf9HQ8PMO5Gox2vaB1sebNZkFdy-RJTweXozO63hj8yLN-Smbj_OvwImj7LgSWgzADxphONJxkJLYcLFxSpA7ckExt6qwwOnIO0kLhYidMJExhE2lFKLUW3jkHLuQZOayWlX9BaCyltUYUSRobhnAxZlPpwyQ1WWE1L3qEd8JWtiUlx94Y16pDn81VpySFSlJhjHSmPdLfrls1tBz3rsg6Xao9A1MQO-5de9wpX7VbfK3AdcHhGNLNuEfebIdhc-IfF1355QbmwHGUc57E8Ijnja1sXxfxu1mGI3LPirYTkPh7f6Qqv9cE4By7qqZhj7yv7e0fJaAmo-nk42SUf5vmM7wfIjDx5X_I5RV5gFdNaeYxOQRb8yeQo_0wr-tN-AeuXjiK
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF6VcoALAgo0UGCREGoPbvzaXfsYEoc0pD7QBvW22octHDVO1BAEF347M35EiSpUJK7e2ZW1Mzsza3_zDSHveQxZN8R5h6tIO6HNfEdr4Tm58jIXnCGELCxwPk_5aBqOr9jVHum3tTAIq2x8f-3TK2_dPOk2u9ldFkX3AoyTMxFGHlKuuwG7R-6HcHyxjcHp7y2cB6t6CKK0g-JbZcKz02Jmsx9ltkaMl6jJO4O_RajbGehtIOV2gltFqOFj8qhJLWmvfvsnZC8rn5KDXgnX6vkv-oFWYM_qK_oBuU6WSMOJFYz0pm5HDwqii5x-SSYpVaWln3oDjxYlhQyR5khzAGsbhOb-pMfD_gnKKrDa1ZxW1Zo36zm1DZUnPe5dDE7oaq3xK8_qGZkOk8v-yGkaLziGwW46YRiqQMFVRmDPwdwGeWTBD4nIRNZwrTxrIS_k1rdce1znJhCGu0IpnllrwYc8J_vloswOCfWFMEbzHPSiQ8SLhSYSmRtEOs6NYnmHsHazpWlYybE5xrVs4Wcz2SpJopKk6yOfaYd0N_OWNS_HnTPiVpdyx8IkBI875x61ypfNGV9J8F1wO4Z80--Qd5thOJ34y0WV2WINMnAfZYwFPizxoraVzesigDeOcUTsWNFGAJm_d0fK4lvFAM6wrWrkdsjHyt7-cQfkeJCOz8aD5GuaTPG5i8jEl_-xL2_Jg9Hl-UROztLPr8hDHKnrNI_IPthd9hoStu_6TXUg_wBNTzum
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epigenetic+regulation+of+RELN+and+GAD1+in+the+frontal+cortex+%28FC%29+of+autism+spectrum+disorder+%28ASD%29+subjects&rft.jtitle=International+journal+of+developmental+neuroscience&rft.au=Zhubi%2C+A&rft.au=Chen%2C+Y&rft.au=Guidotti%2C+A&rft.au=Grayson%2C+DR&rft.date=2017-11-01&rft.issn=0736-5748&rft.eissn=1873-474X&rft.volume=62&rft.spage=63&rft.epage=72&rft_id=info:doi/10.1016%2Fj.ijdevneu.2017.02.003&rft_id=info%3Apmid%2F28229923&rft.externalDocID=PMC5575980
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0736-5748&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0736-5748&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0736-5748&client=summon